Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-10

FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the pentazocine hydrochloride and naloxone hydrochloride combination product, continuing its availability for relief…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentazocine and Naloxone (Pentazocine hydrochloride and naloxone hydrochloride)

Snippet

SUPPL AP for PENTAZOCINE AND NALOXONE (PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE)